CRSwNP: Mepolizumab shows convincing results in real-world settings

被引：0
|
作者：
不详
机构：
来源：
ALLERGO JOURNAL | 2024年 / 33卷 / 08期
关键词：
D O I：
10.1007/s15007-024-6412-0
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：58 / 58
页数：1
相关论文
共 50 条
  • [31] Real-World Effectiveness of Dupilumab Through 18 Months in Patients with CRSwNP and AERD: Results from the Global AROMA Registry
    White, Andrew
    Buchheit, Kathleen
    Laidlaw, Tanya
    Heffler, Enrico
    Cornet, Marjolein
    Xia, Changming
    Kim, Helen
    Corbett, Mark
    Jacob-nara, Juby
    Radwan, Amr
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2025, 155 (02) : AB302 - AB302
  • [32] Real-world Omalizumab and Mepolizumab treated Difficult Asthma Phenotypes and their Clinical Outcomes
    Fong, Wei Chern Gavin
    Azim, Adnan
    Knight, Deborah
    Mistry, Heena
    Freeman, Anna
    Felongco, Mae
    Kyyaly, Aref
    Harvey, Matthew
    Dennison, Paddy
    Zhang, Hongmei
    Howarth, Peter
    Arshad, Syed Hasan
    Kurukulaaratchy, Ramesh
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [33] Predicting real-world response to mepolizumab in severe asthma using machine learning
    Usuba, Koyo
    Zhang, Lingjiao
    Liu, Xinyang
    Han, Tim
    Nightingale, Natalie
    Tehrani, Ali
    Zhang, Shiyuan
    Howarth, Peter
    Alfonso-Cristancho, Rafael
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [34] Effectiveness and safety of mepolizumab in real-world clinical practice: The REALITI-A study
    Harrison, T.
    Canonica, G.
    Gemzoe, K.
    Maxwell, A.
    Yang, S.
    Joksaite, S.
    O'Reilly, R.
    Van Dyke, M.
    Albers, F. C.
    Kwon, N.
    PNEUMOLOGIE, 2020, 74 : S25 - S25
  • [35] Mepolizumab Treatment in Severe Pediatric Asthma: First Multicentric Real-World Data
    Wetzke, Martin
    Funken, Dominik
    Ahrens, Frank O.
    Gappa, Monika
    Hansen, Gesine
    Koerner-Rettberg, Cordula
    Koester, Holger
    Schulze, Johannes
    Schwerk, Nicolaus
    Zielen, Stefan
    Happle, Christine
    KLINISCHE PADIATRIE, 2022, 234 (05): : 305 - 308
  • [36] Real-World Effectiveness of Mepolizumab in Patients with Allergic and Non-Allergic Asthma
    Silver, Jared
    Steffens, Andrea
    Chastek, Benjamin
    Deb, Arijita
    JOURNAL OF ASTHMA AND ALLERGY, 2024, 17 : 261 - 271
  • [37] Real-world Impact of Switching to Mepolizumab From Other Biologics in Patients With Asthma
    Deb, A.
    Gao, C.
    Corbridge, T.
    Stach-Klysh, A.
    Hilts, A.
    Lejeune, D.
    Laliberte, F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [38] MEPOLIZUMAB REDUCES EXACERBATIONS IN SEVERE EOSINOPHILIC ASTHMA: A REAL-WORLD STUDY.
    Harvey, E.
    Langton, D.
    Farah, C.
    Gillman, A.
    Harrington, J.
    Hew, M.
    Katelaris, C.
    Kritikos, V
    Radhakrishna, N.
    Stevens, S.
    Gibson, P.
    RESPIROLOGY, 2020, 25 : 105 - 105
  • [39] Characteristics of patients receiving mepolizumab in real-world practice - REALITI-A study
    Kwon, Namhee
    Gemzoe, Kim
    Worsley, Sally
    Gunsoy, Necdet
    Joksaite, Sandra
    Van Dyke, Melissa
    Bettinson, Carys
    Albers, Frank
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [40] Real-world Omalizumab and Mepolizumab Treated Difficult Asthma Phenotypes and Their Clinical Outcomes
    Fong, W. C. G.
    Azim, A.
    Knight, D.
    PEDIATRICS, 2021, 148 : S64 - S65
12345